PCI Deferral Based on Fractional Flow Reserve or Optical Coherence Tomography: Two-Year Results of the Forza Trial.
FFR
OCT
fractional flow reserve
optical coherence tomography
personalized medicine
Journal
Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
04
06
2022
revised:
25
07
2022
accepted:
10
08
2022
medline:
25
10
2022
pubmed:
25
10
2022
entrez:
30
7
2024
Statut:
epublish
Résumé
The "FFR or OCT Guidance to Revascularize Intermediate Coronary Stenosis Using Angioplasty" (FORZA) trial showed that in patients with angiographically intermediate coronary lesions (AICLs), optical coherence tomography (OCT) guidance of percutaneous coronary intervention (PCI) reduced the occurrence of the composite endpoint of major adverse cardiac events (MACE) or significant angina at 13 months, while fractional flow reserve (FFR) guidance was associated with a higher rate of medical management and with lower costs. Safety of PCI deferral when FFR This is a subgroups analysis of the FORZA Trial focusing on the clinical outcome of patients in whom PCI was originally deferred. In details, patients with AICLs were randomized to FFR or OCT imaging. In the FFR arm, PCI was deferred if FFR was From a total of 350 patients with 446 AICLs enrolled in the trial (176 randomized to FFR and 174 to OCT), based on the predefined FFR and OCT criteria, PCI was deferred in 119 patients (67.6%) in the FFR arm, and in 82 patients (47.1%) in the OCT arm. At 24-months follow-up, significant residual angina (defined as a value PCI-deferral based on OCT (using the FORZA trial criteria) is safe and associated with numerically less events at 24-months follow up. FFR guidance is still associated with a higher number of patients managed by optimal medical therapy alone.
Identifiants
pubmed: 39076180
doi: 10.31083/j.rcm2311361
pii: S1530-6550(22)00662-7
pmc: PMC11269053
doi:
Types de publication
Journal Article
Langues
eng
Pagination
361Informations de copyright
Copyright: © 2022 The Author(s). Published by IMR Press.
Déclaration de conflit d'intérêts
A.M.L. received speaking honoraria from Abbott, Medtronic, Abiomed and from Bracco Imaging, F.B, C.T and C.A received speaker’s fees from Abbott, Medtronic, and Abiomed. G.Z., A.Z., D.G., F.D.G., F.B., R.V. and F.C have no conflicts of interest. Antonio Maria Leone is serving as one of the Editorial Board members of this journal. We declare that Antonio Maria Leone had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Manuel Martínez-Sellés, Grigorios Tsigkas, Athanasios Moulias and Anastasios Apostolos.